2018 Call for Papers
Now in its 13th year, the Neurotech Investing & Partnering Conference is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients.
Topics may include but are not limited to:
- Investing in Neurotech
- Alzheimer’s and Cognitive Disorders
- Brain Injury and Stroke
- Strategies in CNS Drug and Device Development
- Parkinson’s and Movement Disorders
- Partnering and Licensing in Neurotech
- Next-Generation Psychiatry
- Frontiers in Neurotechnology
- Orphan Diseases
- Emerging Companies
Companies who would like to present on new treatments and diagnostics for the brain and nervous system, and continue to grow their investments are asked to click here to submit a topic.
The deadline for submission is Friday, November 10, 2017.
For more details on the conference, please contact:
Carla Lema Tome
Neurotechnology Industry Organization
For partnering and sponsorship information, please contact:
Manager, Business Development
Cambridge Healthtech Institute